Imported strongyloidosis: A longitudinal analysis of 31 cases

Journal of Travel Medicine

Volumn 12, Issue 2, 2005, Pages 80-84

  Nuesch, Reto ^a   Zimmerli, Lukas ^a   Stockli, Rolf ^a   Gyr, Niklaus ^a   Hatz, Christoph F R ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; ENDEMIC DISEASE; FEMALE; HIGH RISK PATIENT; HUMAN; IMMIGRATION; LONGITUDINAL STUDY; MALE; PARASITOSIS; RISK ASSESSMENT; SEROCONVERSION; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TRAVEL; TROPICAL DISEASE;

EID: 17844402253     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2005.12204     Document Type: Article

References (36)

1. Jelinek T, Schulte C, Behrens R, et al. Imported falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis 2002; 34:572-576.
2. Nuesch R, Scheller M, Gyr N. Hospital admissions for malaria in Basel, Switzerland: an epidemiological review of 150 cases. J Travel Med 2000; 7:95-97.
3. Ferreira MS, Nishioka Sde A, Borges AS, et al. Strongyloidiasis and infection due to human immunodeficiency virus: 25 cases at a Brazilian teaching hospital, including seven cases of hyperinfection syndrome. Clin Infect Dis 1999; 28:154-155.
4. Heyworth MF. Parasitic diseases in immunocompromised hosts. Cryptosporidiosis, isosporiasis, and strongyloidiasis. Gastroenterol Clin North Am 1996; 25:691-707.
5. Lessnau KD, Can S, Talavera W. Disseminated Strongyloides stercoralis in human immunodeficiency virus-infected patients. Treatment failure and a review of the literature. Chest 1993; 104:119-122.
6. Morgello S, Soifer FM, Lin CS, Wolfe DE. Central nervous system Strongyloides stercoralis in acquired immunodeficiency syndrome: a report of two cases and review of the literature. Acta Neuropathol (Berl) 1993; 86:285-288.
7. Maayan S, Wormser GP, Widerhorn J, et al. Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. Am J Med 1987; 83:945-948.
8. Igra-Siegman Y, Kapila R, Sen P, et al. Syndrome of hyper-infection with Strongyloides stercoralis. Rev Infect Dis 1981; 3:397-407.
9. Muennig P, Pallin D, Sell RL, Chan MS. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. N Engl J Med 1999; 340:773-779.
10. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis 1989; 11:755-767.
11. Scaglia M, Brustia R, Gatti S, et al. Autochthonous strongyloidiasis in Italy: an epidemiological and clinical review of 150 cases. Bull Soc Pathol Exot Filiales 1984; 77:328-332.
12. Sanchez PR, Guzman AP, Guillen SM, et al. Endemic strongyloidiasis on the Spanish Mediterranean coast. QJM 2001; 94:357-363.
13. Doury P. [Autochthonous anguilluliasis in France]. Bull Soc Pathol Exot 1993; 86:116.
14. Berthoud F, Berthoud S. 18 cases of anguilluliasis diagnosed at Geneva. Schweiz Med Wochenschr 1975; 105:1110-1115.
15. Garcia L, Bruckner D. Diagnostic medical parasitology. Washington: American Society for Microbiology, 1993.
16. Speiser F. Serodiagnosis of tissue dwelling parasites: application of a multi-antigen enzyme-linked immunosorbent assay (ELISA) for screening. Ann Soc Belg Med Trop 1982; 62:103-120.
17. Cimerman S, Cimerman B, Lewi DS. Prevalence of intestinal parasitic infections in patients with acquired immunodeficiency syndrome in Brazil. Int J Infect Dis 1999; 3:203-206.
18. Agi PI. Comparative helminth infections of man in two rural communities of the Niger Delta, Nigeria. West Afr J Med 1997; 16:232-236.
19. Kasuya S, Khamboonruang C, Amano K, et al. Intestinal parasitic infections among schoolchildren in Chiang Mai, northern Thailand: an analysis of the present situation. J Trop Med Hyg 1989; 92:360-364.
20. Genta RM, Weesner R, Douce RW, et al. Strongyloidiasis in US veterans of the Vietnam and other wars. JAMA 1987; 258:49-52.
21. Pelletier LL Jr. Chronic strongyloidiasis in World War II Far East ex-prisoners of war. Am J Trop Med Hyg 1984;33:55-61.
22. Milder JE, Walzer PD, Kilgore G, et al. Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroenterology 1981; 80:1481-1488.
23. Grove DI. Strongyloidiasis in allied ex-prisoners of war in south-east Asia. Br Med J 1980; 280:598-601.
24. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001; 33:1040-1047.
25. Nielsen PB, Mojon M. Improved diagnosis of strongyloides stercoralis by seven consecutive stool specimens. Zentralbl Bakteriol Mikrobiol Hyg [A] 1987; 263:616-618.
26. Zaha O, Hirata T, Kinjo F, Saito A. Strongyloidiasis-progress in diagnosis and treatment. Intern Med 2000; 39:695-700.
27. Sato Y, Kobayashi J, Toma H, Shiroma Y. Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg 1995; 53:248-250.
28. Libman MD, MacLean JD, Gyorkos TW. Screening for schistosomiasis, filariasis, and strongyloidiasis among expatriates returning from the tropics. Clin Infect Dis 1993; 17:353-359.
29. Gyorkos TW, Genta RM, Viens P, MacLean JD. Seroepidemiology of Strongyloides infection in the Southeast Asian refugee population in Canada. Am J Epidemiol 1990; 132:257-264.
30. Genta RM. Predictive value of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of strongyloidiasis. Am J Clin Pathol 1988; 89:391-394.
31. Sudarshi S, Stumpfle R, Armstrong M, et al. Clinical presentation and diagnostic sensitivity of laboratory tests for Strongyloides stercoralis in travellers compared with immigrants in a non-endemic country. Trop Med Int Health 2003; 8:728-732.
32. Loutfy MR, Wilson M, Keystone JS, Kain KC. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg 2002; 66:749-752.
33. Toma H, Sato Y, Shiroma Y, et al. Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan. Southeast Asian J Trop Med Public Health 2000; 31:147-151.
34. Marti H, Haji HJ, Savioli L, et al. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg 1996; 55:477-481.
35. Gann PH, Neva FA, Gam AA. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994; 169:1076-1079.
36. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg 1994; 88:344-345.